EUVIMEDEUVIMED entdecken
Fallbericht

Intrauterine management and outcomes of persistent fetal atrial flutter: A case report

Runxuan Du, Fangna Wang, Yuewen Dong, Wei Chu, Lishuang Ma, Jian Gao

Birth Defects Research · 2023

DOI: 10.1002/bdr2.2220 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Birth Defects Research, 2023. Verfasst von Runxuan Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproduction and Genetics, Hebei General Hospital, Shijiazhuang, China. Hauptthemen laut MEDLINE: Atrial Flutter, Fetal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fetal atrial flutter (AF), accounting for 30% of all fetal tachyarrhythmias, predominantly (over 80%) manifests as a 2:1 atrioventricular conduction. Swift referral and timely intervention become imperative in instances of severe persistent arrhythmia. Case Presentation We discuss the case of a 32‐year‐old multiparous Chinese woman, at 30 +2 weeks of gestation, wherein an ultrasonographic examination revealed persistent fetal AF (atrial rate ranging from 219 to 445 beats/min and ventricular rate from 219 to 228 beats/min, with a 2:1 or 1:1 down transmission) and minor ascites. Despite the maternal ingestion of digoxin and sotalol, the fetal heart rhythm remained uncorrected. Following this, at 32 +3 weeks of gestation, an intramuscular injection of cedilanid, guided by ultrasound, was administered to the fetus. Postoperatively, the fetal ventricular rate demonstrated a decline after 6 days, and the ascites resolved. Subsequently, at 33 +3 weeks, a cesarean section was necessitated due to maternal intolerance to the medication, resulting in the delivery of the infant. Remarkably, the infant's cardiac rhythm spontaneously converted to sinus rhythm within 5 min of birth. A follow‐up conducted 1 year postpartum revealed no recurrence of AF.

Conclusions

This case illustrates that in the event of transplacental drug treatment failure, intrauterine therapeutic intervention should be considered. Moreover, it highlights the encouraging prognosis associated with fetal AF, as the cardiac rhythm spontaneously reverted to sinus rhythm postbirth in this instance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FlutterFetal DiseasesPregnancyHumansFemaleAdultAnti-Arrhythmia AgentsCesarean SectionAscitesArrhythmias, CardiacFetus

Stichwörter der Autor:innen

case reportdigoxinfetal atrial flutterintrauterine treatmentsotalol

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Reproduction and Genetics, Hebei General Hospital, Shijiazhuang, China.

Zitieren

APA

Du, R., Wang, F., Dong, Y., Chu, W., Ma, L., & Gao, J. (2023). Intrauterine management and outcomes of persistent fetal atrial flutter: A case report. Birth Defects Research. https://doi.org/10.1002/bdr2.2220

Vancouver

Du R, Wang F, Dong Y, Chu W, Ma L, Gao J. Intrauterine management and outcomes of persistent fetal atrial flutter: A case report. Birth Defects Research. 2023. doi:10.1002/bdr2.2220

BibTeX
@article{Du2023,
  author = {Du, Runxuan and Wang, Fangna and Dong, Yuewen and Chu, Wei and Ma, Lishuang and Gao, Jian},
  title = {Intrauterine management and outcomes of persistent fetal atrial flutter: A case report},
  journal = {Birth Defects Research},
  year = {2023},
  doi = {10.1002/bdr2.2220}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche